Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes
出版年份 2015 全文链接
标题
Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes
作者
关键词
-
出版物
Journal of Immunology Research
Volume 2015, Issue -, Pages 1-9
出版商
Hindawi Limited
发表日期
2015-08-18
DOI
10.1155/2015/353461
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
- (2014) Georgina Tzanakaki et al. BMC MICROBIOLOGY
- Neisseria meningitidisB vaccines: recent advances and possible immunization policies
- (2014) Roberto Gasparini et al. Expert Review of Vaccines
- Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years
- (2014) R. Gasparini et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada
- (2014) Hong Anh T. Tu et al. VACCINE
- Reverse vaccinology in the 21st century: improvements over the original design
- (2013) Claudio Donati et al. Annals of the New York Academy of Sciences
- Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
- (2013) Ulrich Vogel et al. LANCET INFECTIOUS DISEASES
- Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development
- (2013) Bas van de Waterbeemd et al. PLoS One
- Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage
- (2013) Giacomo Frosi et al. VACCINE
- Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
- (2013) Julie A. Bettinger et al. VACCINE
- Interlaboratory Standardization of the Sandwich Enzyme-Linked Immunosorbent Assay Designed for MATS, a Rapid, Reproducible Method for Estimating the Strain Coverage of Investigational Vaccines
- (2012) Brian D. Plikaytis et al. Clinical and Vaccine Immunology
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- Transcriptional Regulation of thenadAGene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine
- (2012) Luca Fagnocchi et al. INFECTION AND IMMUNITY
- The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccines
- (2012) Ulrich Vogel et al. VACCINE
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- (2012) Eva Hong et al. VACCINE
- A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp
- (2012) David M. Vu et al. Scientific Reports
- Preclinical evidence for the potential of a bivalent fHBP vaccine to preventNeisseria meningitidisSerogroup C Disease
- (2011) Shannon L. Harris et al. Human vaccines & immunotherapeutics
- Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
- (2011) David M. Vu et al. VACCINE
- Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
- (2011) Heike Claus et al. VACCINE
- Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
- (2010) J. Lucidarme et al. Clinical and Vaccine Immunology
- Meningococcal carriage by age: a systematic review and meta-analysis
- (2010) Hannah Christensen et al. LANCET INFECTIOUS DISEASES
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus
- (2010) Marzia M. Giuliani et al. VACCINE
- Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1
- (2010) Brunella Brunelli et al. VACCINE
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- The modular architecture of meningococcal factor H-binding protein
- (2009) P. T. Beernink et al. MICROBIOLOGY-SGM
- Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
- (2009) Stefania Bambini et al. VACCINE
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
- A Novel Phase Variation Mechanism in the Meningococcus Driven by a Ligand-Responsive Repressor and Differential Spacing of Distal Promoter Elements
- (2009) Matteo M. E. Metruccio et al. PLoS Pathogens
- Complement‐Dependent Synergistic Bactericidal Activity of Antibodies against Factor H–Binding Protein, a Sparsely Distributed Meningococcal Vaccine Antigen
- (2008) Jo Anne Welsch et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now